Cargando…

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

Human kallikrein 6 protein is a newly discovered human kallikrein. We determined the amount of human kallikrein 6 in extracts of 182 ovarian tumours and correlated specific activity (ng hK6 mg(−1) total protein) with clinicopathological variables documented at the time of surgical excision and with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoffman, B R, Katsaros, D, Scorilas, A, Diamandis, P, Fracchioli, S, Rigault de la Longrais, I A, Colgan, T, Puopolo, M, Giardina, G, Massobrio, M, Diamandis, E P
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2002
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364256/ https://www.ncbi.nlm.nih.gov/pubmed/12232761 http://dx.doi.org/10.1038/sj.bjc.6600533

Ejemplares similares

Human kallikrein gene 13 (KLK13) expression by quantitative RT–PCR: an independent indicator of favourable prognosis in breast cancer
por: Chang, A, et al.
Publicado: (2002)

The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer
por: Yousef, G M, et al.
Publicado: (2002)

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer
por: Kim, H, et al.
Publicado: (2001)

Kallikrein gene downregulation in breast cancer
por: Yousef, G M, et al.
Publicado: (2004)

Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis
por: Yousef, G M, et al.
Publicado: (2002)

Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance
por: Luo, L-Y, et al.
Publicado: (2002)

Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues
por: Nakamura, T, et al.
Publicado: (2003)

Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects
por: Shan, S J C, et al.
Publicado: (2007)

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
por: Talieri, M, et al.
Publicado: (2009)

Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library
por: Luo, L-Y, et al.
Publicado: (2002)

Characterisation of human kallikrein 6/protease M expression in ovarian cancer
por: Ni, X, et al.
Publicado: (2004)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma
por: Fontanini, G, et al.
Publicado: (2002)

Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.
por: Levesque, M. A., et al.
Publicado: (1995)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

Analysis of the expression and localisation of a LAP protein, human scribble, in the normal and neoplastic epithelium of uterine cervix
por: Nakagawa, S, et al.
Publicado: (2004)

Kallikrein 6 as a Serum Prognostic Marker in Patients with Aneurysmal Subarachnoid Hemorrhage
por: Martínez-Morillo, Eduardo, et al.
Publicado: (2012)

Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer
por: Scorilas, A, et al.
Publicado: (2001)

Histochemical and immunohistochemical characterization of chordoma in ferrets
por: YUI, Takeshi, et al.
Publicado: (2015)

Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies
por: Schmitt, Manfred, et al.
Publicado: (2013)

Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status
por: Fritzsche, F, et al.
Publicado: (2006)

Prognostic significance of multiple kallikreins in high-grade astrocytoma
por: Drucker, Kristen L., et al.
Publicado: (2015)

Cocaine Detection by a Laser-Induced Immunofluorometric Biosensor
por: Paul, Martin, et al.
Publicado: (2021)

A new enzyme-linked immunosorbent assay (ELISA) for human free and bound kallikrein 9
por: Filippou, Panagiota, et al.
Publicado: (2017)

Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA
por: Maire, F, et al.
Publicado: (2002)

Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues
por: Bernini, G P, et al.
Publicado: (2002)

Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma
por: Kallio, J P, et al.
Publicado: (2003)

Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer
por: Kronqvist, P, et al.
Publicado: (2002)

Fenretinide stimulates redox-sensitive ceramide production in breast cancer cells: potential role in drug-induced cytotoxicity
por: Rehman, F, et al.
Publicado: (2004)

Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing
por: Vassilakos, P, et al.
Publicado: (2002)

Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans
por: Collins, P, et al.
Publicado: (2002)

Wnt-signalling pathway in ovarian epithelial tumours: increased expression of β-catenin and GSK3β
por: Rask, K, et al.
Publicado: (2003)

Nuclear survivin as a biomarker for non-small-cell lung cancer
por: Lu, B, et al.
Publicado: (2004)

Predicting aggressive outcome in T1N0M0 breast cancer
por: Kronqvist, P, et al.
Publicado: (2004)

Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1
por: Ebert, M P A, et al.
Publicado: (2002)

Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck
por: Mhawech, P, et al.
Publicado: (2004)

Tumour-derived TGF-β1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells
por: Lewis, M P, et al.
Publicado: (2004)

Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer
por: Dirix, L Y, et al.
Publicado: (2002)

G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis
por: Jézéquel, P, et al.
Publicado: (2004)

A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein
por: Liggins, A P, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_66ettiik5bkh7dueb30vd7vmn3